Steep Hill (XCNQ:STPH) Debt-to-Equity : 0.01 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Steep Hill Debt-to-Equity?

Steep Hill's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.02 Mil. Steep Hill's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.00 Mil. Steep Hill's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$1.65 Mil. Steep Hill's debt to equity for the quarter that ended in Dec. 2023 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Steep Hill's Debt-to-Equity or its related term are showing as below:

XCNQ:STPH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.11 Max: 0.37
Current: 0.01

During the past 5 years, the highest Debt-to-Equity Ratio of Steep Hill was 0.37. The lowest was 0.01. And the median was 0.11.

XCNQ:STPH's Debt-to-Equity is ranked better than
99.88% of 848 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs XCNQ:STPH: 0.01

Steep Hill Debt-to-Equity Historical Data

The historical data trend for Steep Hill's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steep Hill Debt-to-Equity Chart

Steep Hill Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

0.37

0.12

0.10

0.01

Steep Hill Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial													0.10	0.03	0.03	0.04	0.01

Competitive Comparison of Steep Hill's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Steep Hill's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Steep Hill's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Steep Hill's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Steep Hill's Debt-to-Equity falls into.

Steep Hill Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Steep Hill's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.019	+	0)	/	1.651
	=	0.01

Steep Hill's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.019	+	0)	/	1.651
	=	0.01

Steep Hill (XCNQ:STPH) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Steep Hill Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Steep Hill's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Steep Hill (XCNQ:STPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Steep Hill Inc (XCNQ:STPH) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Adelaide Street West, Suite 2500, Toronto, ON, CAN, M5H 1T1

Website

https://www.steephill.com

Steep Hill Inc is a science and technology health and wellness company focused on the hemp markets inclusive of plant-based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals. Currently the company, through its subsidiaries holds three industrial hemp licences for the purposes of supplying the global market with medicinal and wellness cannabidiol and other cannabinoid-based products.

Steep Hill (XCNQ:STPH) Headlines

No Headlines